Melatonin protection from chronic, low-level ionizing radiation

Mutation Research - Reviews in Mutation Research

Volumn 751, Issue 1, 2012, Pages 7-14

  Reiter, Russel J ^a   Korkmaz, Ahmet ^a   Ma, Shuran ^a   Rosales Corral, Sergio ^a   Tan, Dun Xian ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Chronic radiation exposure; Lingering radioactivity; Melatonin; Radioisotopes

Indexed keywords

ALPHA TOCOPHEROL; AMIFOSTINE; ANTIOXIDANT; CELL DNA; CELL NUCLEUS DNA; CESIUM 137; COBALT 60; IODINE 131; MELATONIN; N1 ACETYL N2 FORMYL 5 METHOXYKYNURAMINE; OCTREOTIDE; PLASMID DNA; SCAVENGER; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CANCER CELL; DNA DAMAGE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; LYMPHOCYTE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION PROTECTION; RADIOACTIVITY; REVIEW; SURVIVAL RATE;

ANIMALIA;

EID: 84862208675     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2011.12.002     Document Type: Review

References (123)

1. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:7915-7922.
2. Brenner D.J., Ward J.F. Constraints on energy deposition and target size of multiple damaged sites associated with DNA double-strand breaks. Int. J. Radiat. Biol. 1992, 61:737-748.
3. Radford I.R. Evidence for a general relationship between the induced level of DNA double-strand breakage and cell-killing after X-irradiation of mammalian cells. Int. J. Radiat. Biol. 1986, 49:611-620.
4. Murray D., Prager A., Milas L. Radioprotection of cultured mammalian cells by the aminothiols WR-1065 and WR-255591: correlation between protection against DNA double-strand breaks and cell killing after γ-radiation. Radiat. Res. 1989, 120:154-163.
5. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 1991, 12:151-180.
6. Tan D.X., Reiter R.J., Manchester L.C., Yan M.T., El-Sawi M., Sainz R.M., Mayo J.C., Kohen R., Allegra M., Hardeland R. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr. Top. Med. Chem. 2002, 2:181-198.
7. Escames G., Acuna-Castroviejo D., Lopez L.C., Tan D.X., Maldonado M.D., Sanchez-Hidalgo M., Leon J., Reiter R.J. Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J. Pharm. Pharmacol. 2006, 58:1153-1165.
8. Jan J.E., Wasdell M.B., Freeman R.D., Bax M. Evidence supporting the use of melatonin in short gestation agents. J. Pineal Res. 2007, 42:22-27.
9. Lewy A.J. Melatonin and human chronobiology. Cold Spring Harb. Symp. Quant. Biol. 2007, 72:623-636.
10. Cardinali D.P., Furio A.M., Brusco L.I. Clinical aspects of melatonin intervention in Alzheimer's disease progression. Curr. Neuropharmacol. 2010, 8:218-227.
11. Tan D.X., Chen L.D., Poeggeler B., Manchester L.C., Reiter R.J. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1993, 1:57-60.
12. Hardeland R. Antioxidant protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005, 27:119-130.
13. Reiter R.J., Paredes S.D., Manchester L.C., Tan D.X. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit. Rev. Biochem. Mol. Biol. 2009, 44:175-200.
14. Velkov Z.A., Zh Velkov Y., Galunska B.T., Paskalev D.N., Tadjer A.V. Melatonin: quantum-chemical and biochemical investigation of antioxidant activity. Eur. J. Med. Chem. 2009, 44:2834-2839.
15. Paradies G., Petrosillo G., Paradies V., Reiter R.J., Ruggiero F.M. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J. Pineal Res. 2010, 48:297-310.
16. Galano A., Tan D.X., Reiter R.J. Melatonin as a natural ally against oxidative stress: a physiochemical examination. J. Pineal Res. 2011, 51:1-16.
17. Reiter R.J. Melatonin: lowering the high price of free radicals. News Physiol. Sci. 2000, 15:246-250.
18. Aranda M., Albendea C.D., Lostale F., Lopez-Pingarron L., Fuentes-Broto L., Martinez-Ballarin E., Reiter R.J., Perez-Castejon M.C., Garcia J.J. In vivo hepatic oxidative stress because of carbon tetrachloride toxicity: protection by melatonin and pinoline. J. Pineal Res. 2010, 48:78-85.
19. Chahbouni M., Escames G., Venegas C., Sevilla B., Garcia J.A., Lopez L.C., Munoz-Hoyos A., Molina-Carballo A., Acuna-Castroviejo D. Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy. J. Pineal Res. 2010, 48:282-289.
20. Hong Y., Palaksha K.J., Park K., Park S., Kim H.D., Reiter R.J., Chang K.T. Melatonin plus exercise base neurorehabilitative therapy for spinal cord injury. J. Pineal Res. 2010, 40:201-209.
21. Mukherjee D., Roy S.G., Bandyopadhyay A., Chattopadhyay A., Basu A., Mitra E., Kr Ghosh A., Reiter R.J., Bandyopadhyay D. Melatonin protects against isoproterenol-induced myocardial injury in the rat: antioxidative mechanisms. J. Pineal Res. 2010, 48:251-262.
22. Acuna-Castroviejo D., Lopez L.C., Escames G., Lopez A., Garcia J.A., Reiter R.J. Melatonin-mitochondrial interplay in health and disease. Curr. Top. Med. Chem. 2011, 11:221-240.
23. Reiter R.J., Tan D.X., Manchester L.C., Qi W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem. Biophys. 2001, 34:237-256.
24. Tan D.X., Manchester L.C., Reiter R.J., Qi W., Karbownik M., Calvo J.R. Significance of melatonin in antioxidative defense system. Biol. Signals Recept. 2000, 9:137-159.
25. Tan D.X., Manchester L.C., Terron M.P., Flores L.J., Reiter R.J. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species. J. Pineal Res. 2007, 42:28-42.
26. Hardeland R. Melatonin, hormone of darkness and more: occurrence, control mechanisms, actions and bioactive metabolites. Cell. Mol. Life Sci. 2008, 65:2001-2018.
27. Hardeland R. Neuroprotection by radical avoidance: search for suitable agents. Molecules 2009, 14:5054-5102.
28. Tan D.X., Manchester L.C., Reiter R.J., Plummer B.F., Hardies L.J., Weintraub S.T., Vijayalaxmi, Shepherd A.M.M. A novel melatonin metabolite, cyclic 3-hydroxy melatonin: a biomarker of melatonin interaction with hydroxyl radicals. Biochem. Biophys. Res. Commun. 1998, 253:614-620.
29. Tan D.X., Manchester L.C., Burkhardt S., Sainz R.M., Mayo J.C., Kohen R., Shohami E., Huo Y.S., Hardeland R., Reiter R.J. N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J. 2001, 15:2294-2296.
30. Ressmeyer A.R., Mayo J.C., Zelosko J.C., Sainz R.M., Tan D.X., Poeggeler B., Antolin I., Zsizsik B.K., Reiter R.J., Hardeland R. Antioxidant properties of the melatonin metabolite N-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rep. 2003, 8:205-213.
31. Hardeland R., Tan D.X., Reiter R.J. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J. Pineal Res. 2009, 47:109-126.
32. Barlow-Walden L.R., Reiter R.J., Abe M., Pablos M., Menendez-Pelaez A., Chen L.D., Poeggeler B. Melatonin stimulates brain glutathione peroxidase activity. Neurochem. Int. 1995, 26:497-502.
33. Pablos M.I., Agapito M.T., Gutierrez R., Recio J.M., Reiter R.J., Barlow-Walden L.R., Acuna-Castroviejo D., Menendez-Pelaez A. Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J. Pineal Res. 1995, 19:111-115.
34. Rodriguez C., Mayo J.C., Sainz R.M., Antolin I., Herrera F., Martin V., Reiter R.J. Regulation of antioxidant enzymes: a significant role for melatonin. J. Pineal Res. 2004, 36:1-9.
35. Tomas-Zapico C., Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J. Pineal Res. 2005, 39:99-104.
36. Urata Y., Honma S., Goto S., Todoroki S., Cho S., Honma K., Kondo T. Melatonin induces gamma-glutamylcysteine synthase mediated by activator protein-1 in human vascular endothelial cells. Free Radic. Biol. Med. 1999, 27:838-847.
37. Winiarska K., Fraczyk T., Malinska D., Drozak J., Bryla J. Melatonin attenuates diabetes-induced oxidative stress in rabbits. J. Pineal Res. 2006, 40:168-176.
38. Reiter R.J., Manchester L.C., Tan D.X. Neurotoxins: free radical mechanisms and melatonin protection. Curr. Neuropharmacol. 2010, 8:194-210.
39. 2+-mediated permeability transition and beyond in rat brain astrocytes. J. Pineal Res. 2010, 48:20-38.
40. Vera-Ramirez L., Sanchez-Rovira P., Ramirez-Tortosa M.C., Granados-Principal S., Lorente J.A., Quiles J.L. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological basis to develop oxidative-based therapies. Crit. Rev. Oncol. Hematol. 2011, 80:347-369.
41. Reiter R.J., Tan D.X., Kim S.J., Qi W. Melatonin as a pharmacological agent against oxidative damage to lipids and DNA. Proc. West. Pharmacol. Soc. 1998, 41:229-236.
42. Reiter R.J. Oxidative damage to nuclear DNA: amelioration with melatonin. Neuroendocrinol. Lett. 1999, 20:145-150.
43. 2 is protected by the antioxidants, melatonin, N1-acetyl-N2-formyl-5-methoxykynuramine, resveratrol and uric acid. Int. J. Biochem. Cell Biol. 2001, 33:775-783.
44. Cabrera J., Burkhardt S., Tan D.X., Manchester L.C., Karbownik M., Reiter R.J. Antioxidation and toxicant-induced oxidation of lipid and DNA in monkey liver: reduction of molecular damage by melatonin. Pharmacol. Toxicol. 2001, 89:225-230.
45. Karbownik M., Reiter R.J., Qi W., et al. Protective effects of melatonin against oxidation of guanine bases in DNA and decreased microsomal membrane fluidity in rat liver induced by whole body ionizing radiation. Mol. Cell. Biochem. 2000, 211:137-144.
46. Karbownik M., Reiter R.J. Melatonin protects against oxidative stress caused by delta-aminolevulinic acid: implications for cancer reduction. Cancer Invest. 2002, 20:276-286.
47. Vijayalaxmi, Reiter R.J., Meltz M. Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutat. Res. 1995, 346:23-31.
48. Vijayalaxmi, Reiter R.J., Sewerynek E., et al. Marked reduction of radiation-induced micronuclei in human blood lymphocytes pretreated with melatonin. Radiat. Res. 1995, 143:102-106.
49. Vijayalaxmi, Reiter R.J., Herman T.S., et al. Melatonin and radioprotection from genetic damage: in vivo/in vitro studies with human volunteers. Mutat. Res. 1996, 221-228.
50. Koc M., Buyukokuroglu M.E., Taysi S. The effect of melatonin in peripheral blood cells during total body irradiation in rats. Biol. Pharm. Bull. 2002, 65:6-657.
51. Sewerynek E., Ortiz G.G., Reiter R.J., Pablos M.I., Melchiorci D., Daniels W.M.V. Lipopolysaccharide-induce DNA damage is greatly reduced in rats treated with the pineal hormone melatonin. Mol. Cell. Endocrinol. 1996, 17:183-188.
52. Qi W., Reiter R.J., Tan D.X., et al. Tan et al., Chromium (III)-induced 8-hydroxydeoxyguanosine in DNA and its reduction by antioxidants: comparative effects of melatonin, ascorbate and vitamin E. Environ. Health Perspect. 2000, 108:399-802.
53. Reiter R.J., Tan D.X., Manchester L.C., Karbownik M., Calvo J.R. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol. Signals Recept. 2000, 9:160-171.
54. Hussein M.R., Abu-Dief E.E., El-Ghait A.T.A., Adly M.A., Abdelraheem M.H. Morphological evaluation of the radioprotective effects of melatonin against X-ray-induced early and late testis damage in Albino rats: an animal model. Int. J. Exp. Pathol. 2006, 87:237-250.
55. Mediavilla M.D., Sanchez-Barcelo E.J., Tan D.X., Manchester L.C., Reiter R.J. Basic mechanisms involved in the anti-cancer effects of melatonin. Curr. Med. Chem. 2010, 17:4462-4481.
56. Benitez-King G., Soto-Vega E., Ramirez-Rodriguez G. Melatonin modulates microfilament phenotypes in epithelial cells: implications for adhesion and inhibition of cancer cell migration. Histol. Histopathol. 2009, 24:789-799.
57. Cos S., Fernandez R., Guezmes A., Sanchez-Barcelo E.J. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res. 1998, 58:4383-4390.
58. Hill S.M., Frasch T., Xiang S., Yuan L., Duplessis T., Mao L. Molecular mechanisms of melatonin anticancer effects. Integr. Cancer Ther. 2009, 8:337-353.
59. Korkmaz A., Sanchez-Barcelo E.J., Tan D.X., Reiter R.J. Role of melatonin in the epigenetic regulation of breast cancer. Breast Cancer Res. Treat. 2009, 115:13-27.
60. Ortiz-Lopez L., Morales-Mulia S., Ramirez-Rodriguez G., Benitez-King G. ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin in cancer cell progression. J. Pineal Res. 2009, 46:15-21.
61. Jung-Hynes B., Reiter R.J., Ahmad N. Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J. Pineal Res. 2010, 48:9-19.
62. Park S.Y., Jang W.J., Yi E.Y., Jang J.Y., Jung Y., Jeong J.W., Kim Y.J. Melatonin suppresses tumor angiogenesis by inhibiting HIF-1α stabilization under hypoxia. J. Pineal Res. 2010, 48:178-184.
63. Blask D.E., Dauchy R.T., Brainard G.C., Hanifin J.P. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women. Integr. Cancer Ther. 2009, 89:347-353.
64. Cabrera J., Negrin G., Estevez F., Loro J., Reiter R.J., Quintana J. Melatonin decreases cell proliferation and induces melanogenesis in human melanoma SK-MEL-1 cells. J. Pineal Res. 2010, 49:45-54.
65. Gitto E., Karbownik M., Reiter R.J., Dugo L., Gitto P., Barberi S., Cordaro S., Baberi I. Effects of melatonin treatment in septic newborns. Pediatr. Res. 2001, 50:756-760.
66. El-Sokkary G.H., Komel E.S., Reiter R.J. Prophylactic effect of melatonin in reducing lead-induced neurotoxicity in the rat. Cell. Mol. Biol. Lett. 2003, 8:461-470.
67. Tocharus J., Khonthun C., Chongthammakun S., Govitrapong P. Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines. J. Pineal Res. 2010, 48:347-352.
68. Sener G., Jahovic N., Tosun O., Atasoy B.M., Yegen B.C. Melatonin ameliorates ionizing radiation-induced oxidative organ damage in rats. Life Sci. 2003, 74:563-572.
69. Taysi S., Koc M., Buyukokuroglu M.E., Altinkaynak K., Sahin Y.N. Melatonin reduces lipid peroxidation and nitric oxide during irradiation-induced oxidative injury in rat liver. J. Pineal Res. 2003, 34:173-177.
70. Manda K., Ueno M., Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J. Pineal Res. 2007, 42:386-393.
71. Manda K., Reiter R.J. Melatonin maintains adult hippocampal neurogenesis and cognitive functions after irradiation. Prog. Neurobiol. 2010, 90:60-68.
72. McLeon A.S. Radiation doses after Three Mile Island. Lancet 1979, 1(8124):1039.
73. Hill C.R., Adam I., Anderson W., Ott R.J., Sowby F.D. Iodine-131 in human thyroids in Britain following Chernobyl. Nature 1986, 321:655-656.
74. Cardis E., Hatch M. The chernobyl accident - an epidemiological perspective. Clin. Oncol. 2011, 23:251-260.
75. Reiter R.J., Tan D.X., Korkmaz A., Manchester L.C. The disaster in Japan: utility of melatonin in providing protection from ionizing radiation. J. Pineal Res. 2011, 50:357-358.
76. Warren S. Risk of cancer after low-dose radiation. J. Forensic Sci. 1980, 25:721-726.
77. Ward J.F. The yield of DNA double-strand breaks produced intracellularly by ionizing radiation. J. Radiat. Biol. 1990, 57:1141-1150.
78. Sun J., Chen Y., Li M., Ge Z. Role of antioxidative enzymes in ionizing radiation resistance. Free Radic. Biol. Med. 1998, 24:586-593.
79. Vijayalaxmi, Reiter R.J., Tan D.X., et al. Melatonin as a radioprotective agent: a review. Int. J. Oncol. Biol. Phys. 2004, 59:639-653.
80. Citrin D., Cotrim A.P., Hyodo F., Baum B.J., Krishna M.C., Mitchell J.B. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist 2010, 15:360-371.
81. Donnelly E.H., Nembauser J.B., Smith J.M., Kazzi Z.N., Farfan E.B., Chang A.S., Naeem S.F. Acute radiation syndrome: assessment and measurement. South. Med. J. 2010, 103:541-546.
82. Menendez-Pelaez A., Poeggeler B., Reiter R.J., Barlow-Waldon L., Pablos M.I., Tan D.X. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J. Cell. Biochem. 1993, 53:373-382.
83. Menendez-Pelaez A., Reiter R.J. Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization. J. Pineal Res. 1993, 15:59-69.
84. Das B., Bennett P.V., Cutter N.C., Sutherland J.C., Sutherland B.M. Melatonin protects human cells from clustered DNA damages, killing and acquisition of soft agar growth induced by X-rays or 970MeV/n Fe ions. Int. J. Radiat. Biol. 2011, 87:545-555.
85. Garcia J.J., Reiter R.J., Pie J., Ortiz G.G., Cabrera J., Sainz R.M., Acuna-Castroviejo D. Role of pinoline and melatonin in stabilizing hepatic microsomal membranes against oxidative stress. J. Bioenerg. Biomembr. 1999, 31:609-616.
86. Ochoa J.J., Vilchez M.J., Palacias M.A., Garcia J.J., Reiter R.J., Munoz-Hoyos A. Melatonin protects against lipid peroxidation and membrane rigidity in erythrocytes from patients undergoing cardiopulmonary bypass surgery. J. Pineal Res. 2003, 35:104-108.
87. Onal C., Kayaselcuk F., Topkan E., Yavuz M., Bacanli D., Yavuz A. Protective effect of melatonin or octreotide against radiation-induced intestinal injury. Dig. Dis. Sci. 2001, 56:359-367.
88. Zhang L., Wei W., Xu J., Min F., Wang L., Wang X., Cao S., Tan D.X., Qi W., Reiter R.J. Inhibitory effect of melatonin on diquat-induced lipid peroxidation in vivo as assessed by the measurement of F2-isoprostanes. J. Pineal Res. 2006, 40:326-331.
89. Li Z., Nickkholgh A., Yi X., Bruns H., Gross M.L., Hoffmann K., Mohr E., Zorn M., Buchler M.W., Schemmer P. Melatonin protects kidney grafts from ischemia-reperfusion injury through inhibition of NF-kB and apoptosis after experimental kidney transplantation. J. Pineal Res. 2009, 46:365-372.
90. Tripathi D.N., Jena G.B. Effect of melatonin on the expression of Nrf2 and NF-kappa B during cyclophosphamide-induced urinary bladder injury in rat. J. Pineal Res. 2010, 48:324-331.
91. Munoz-Casares F.C., Padillo F.J., Briceno J., Collado J.A., Munoz-Castaneda J.R., Ortega R., Cruz A., Tunez I., Montilla P., Pera C., Muntane J. Melatonin reduces apoptosis and necrosis induced by ischemia/reperfusion injury of the pancreas. J. Pineal Res. 2006, 40:195-203.
92. Reiter R.J. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J. Pharm. Pharmacol. 2002, 54:1299-1321.
93. Esteban S., Garau C., Aparicio S., Moranta D., Barcelo P., Fiol M.A., Rial R. Chronic melatonin treatment and its precursor L-tryptophan improve the monoaminergic neurotransmission and related behavior in aged rat brain. J. Pineal Res. 2010, 48:170-177.
94. Yavuz M.N., Yavuz A.A., Ulku C., Sener M., Yaris E., Kosucu P. Protective effect of melatonin against fractionated irradiation-induced epiphyseal injury in a weanling rat model. J. Pineal Res. 2003, 35:288-294.
95. Blinkenstaff R.T., Brandstodler S.M., Reddy S., Witt R. Potential radioprotective agents: 1. Homologues of melatonin. J. Pharm. Sci. 1994, 83:216-218.
96. Vijayalaxmi R., Meltz M.L., Reiter R.J., et al. Melatonin and protection from whole body radiation: survival studies in mice. Mutat. Res. 1999, 425:21-27.
97. Sliwinski T., Rozej W., Morawiec-Bajda A., Morawiec Z., Reiter R.J., Blasiak J. Protective action of melatonin against DNA damage - chemical inactivation verses base-excision repair. Mutat. Res. 2007, 634:220-227.
98. Yilmaz S., Yilmaz E. Effects of melatonin and vitamin E on oxidative-antioxidative status in rats exposed to irradiation. Toxicology 2006, 222:1-7.
99. Baydas G., Canatan A., Turkoglu A. Comparative analysis of the protective effects of melatonin and vitamin E on streptozocin-induced diabetes mellitus. J. Pineal Res. 2002, 32:225-230.
100. Aktoz T., Aydoglu W., Alagol B., et al. The protective effects of melatonin and vitamin E against renal ischemia-reperfusion injury in rats. Ren. Fail. 2007, 29:535-542.
101. Mayo J.C., Tan D.X., Sainz R.M., Natarajan M., Lopez-Burillo S., Reiter R.J. Protection against oxidative protein damage induced by metal catalyzed reaction or alkylperoxyl radicals: comparative effects of melatonin and other antioxidants. Biomed. Biochim. Acta 2003, 1620:139-150.
102. Murray D. Aminothiols. Radioprotectors, Chemical, Biological and Clinical Perspectives 1997, 53-109. CRC Press, Boca Raton. E.A. Bump, K. Malaker (Eds.).
103. Kligerman M.M., Turrisi A.T., Urtasun R.C., Norfleet A.L., Phillips T.L., Barkley T., Rubin P. Final report on phase I trial of WR-2721 before protracted fractionated radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1988, 14:1119-1122.
104. Schuchter L.M., Glick J.H. The current status of WR-2721 (amifostine): a chemotherapy and radiation therapy protector. Biol. Ther. Cancer Updates 1993, 3:1-10.
105. Kucukakin B., Lykkesfeldt J., Nielsen H.J., Reiter R.J., Rosenberg J., Gogenar I. Utility of melatonin to treat surgical stress after major vascular surgery: a safety study. J. Pineal Res. 2008, 44:426-431.
106. Guenole F., Godbout R., Nicolas A., Franco F., Claustrat B., Baleyte J.M. Melatonin for disordered sleep in individuals with autism spectrum disorder: systematic review and discussion. Sleep Med. Rev. 2011, 15:379-387.
107. Jarratt J. Perioperative melatonin use. Anaesth. Intensive Care 2011, 39:171-183.
108. Nickkholgh A., Schneider H., Sobirey M., Venetz W.P., Hinz U., Pelzl H., Gotthardt D.N., Cekauskas A., Manikas M., Mikalauskas S., Mikalauskene S., Bruns H., Zorn M., Weigand M.A., Buchler M.W., Schemmer P. The use of high-dose melatonin in liver resection is safe: first clinical experience. J. Pineal Res. 2011, 50:381-388.
109. Jahnke G., Marr M., Myers C., Wilson R., Travlos G., Price C. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol. Sci. 1999, 50:271-279.
110. Murley J.S., Kataoka Y., Hallahan D.E., Roberts J.C., Grdina D.J. Activation of NF-kappa B and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells. Free Radic. Biol. Med. 2001, 30:1426-1439.
111. Das K.C., Lewis-Molock Y., White C.W. Activation of NF-kappa B and elevation of MnSOD gene expression by thiol reducing agents in lung adenocarcinoma (A549) cells Am. J. Physiol. 1995, 269:1588-1602.
112. Xiao M., Whitnall M.H. Pharmacological countermeasures for acute radiation syndrome. Curr. Mol. Pharmacol. 2009, 2:122-133.
113. Kopjar N., Miocic S., Ramic S., Milic M., Viculin T. Assessment of the radioprotective effects of amifostine and melatonin on human lymphocytes irradiated with gamma-rays in vitro. Arh. Hig. Rada Toksikol. 2006, 57. 155-153.
114. Topkan E., Tufan H., Yavuz A.A., Bacanli D., Onal C., Kosdak S., Yavuz M.N. Comparison of the protective effects of melatonin on amifostine on radiation-induced epiphyseal injury. Int. J. Radiat. Biol. 2008, 84:796-802.
115. Gitto E., Tan D.X., Reiter R.J., Karbownik M., Manchester L.C., Cuzzocrea S., Fulia F., Barberi I. Individual and synergistic actions of melatonin; studies with vitamin E, vitamin C, glutathione and desferrioxamine in rat liver homogenates. J. Pharm. Pharmacol. 2001, 53:1393-1401.
116. Guha M., Maity P., Choubey V., Mitra K., Reiter R.J., Bandyopadhyay U. Melatonin inhibits free radical-mediated mitochondrial dependent hepatocyte apoptosis and liver damage induced during malarial infection. J. Pineal Res. 2007, 43:372-381.
117. Jou M.J., Peng T.I., Reiter R.J., Jou S.B., Wu H.Y., Wen S.T. Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress induced apoptosis of rat brain astrocytes. J. Pineal Res. 2004, 37:55-70.
118. Sener G., Sehirle A.O., Ayanoglu-Dulger G. Protective effect of melatonin, vitamin E and N-acetylcysteine against acetaminophen toxicity in mice: a comparative study. J. Pineal Res. 2003, 35:61-68.
119. Sainz R.M., Mayo J.C., Rodriguez C., Tan D.X., Lopez-Burillo S., Reiter R.J. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell. Mol. Life Sci. 2003, 60:1407-1426.
120. Leja-Szpak A., Jaworek J., Pierzchalski P., Reiter R.J. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J. Pineal Res. 2010, 49:248-255.
121. Bejarano I., Espino J., Marchena A.M., Barriga C., Paredes S.D., Pariente J.A. Melatonin enhances hydrogen peroxide-induced apoptosis in human promyelocytic leukaemia HL-60 cells. Mol. Cell. Biochem. 2011, 353:167-176.
122. Motilva V., Garcia-Maurino S., Talero E., Illanes M. New paradigms in chronic intestinal inflammation and colon cancer: role of melatonin. J. Pineal Res. 2011, 51:44-60.
123. Lanoix D., Lacasse A.A., Reiter R.J., Vaillancourt C. Melatonin, the smart killer. The human trophoblast as a model. Mol. Cell. Endocrinol. 2012, 348:1-11.